SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-025032
Filing Date
2022-11-14
Accepted
2022-11-14 17:14:53
Documents
67
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q icvx-20220930.htm   iXBRL 10-Q 3548828
2 EX-31.1 icvx-ex31_1.htm EX-31.1 21032
3 EX-31.2 icvx-ex31_2.htm EX-31.2 19518
4 EX-32.1 icvx-ex32_1.htm EX-32.1 11402
5 EX-32.2 icvx-ex32_2.htm EX-32.2 11659
  Complete submission text file 0000950170-22-025032.txt   10521949

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT icvx-20220930_cal.xml EX-101.CAL 42001
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT icvx-20220930.xsd EX-101.SCH 59859
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT icvx-20220930_lab.xml EX-101.LAB 508837
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT icvx-20220930_pre.xml EX-101.PRE 392991
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT icvx-20220930_def.xml EX-101.DEF 255484
61 EXTRACTED XBRL INSTANCE DOCUMENT icvx-20220930_htm.xml XML 1771631
Mailing Address 1930 BOREN AVE., SUITE 1000 SEATTLE WA 98101
Business Address 1930 BOREN AVE., SUITE 1000 SEATTLE WA 98101 (206) 737-0085
Icosavax, Inc. (Filer) CIK: 0001786255 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40655 | Film No.: 221387616
SIC: 2836 Biological Products, (No Diagnostic Substances)